About the Department

Novo Nordisk, a global health care company, is committed to discovering and developing innovative medicines to help people living with diabetes lead longer, healthier lives. To support this, Novo Nordisk is conducting research on stem cell therapy. Stem cell research raises hopes for improved treatment of Type 1 Diabetes and for future treatments with cell transplantation therapy. This treatment could be offered to people with many different serious chronic diseases caused by the degeneration of specific cells, such as Type 1 Diabetes. Type 1 Diabetes is manifested by the selective destruction of the insulin-producing cells in the body, which leads to a life-long dependence on insulin injections to control blood sugar levels. It is usually diagnosed in children and young adults. Cell therapy may offer a better treatment by replacing the lost cells with new insulin-producing cells derived from stem cells, thus avoiding daily multiple insulin injections as well as numerous blood glucose tests. This treatment may also offer better blood glucose control, which is crucial to avoid late-stage complications such as blindness and kidney failure. In this project Novo Nordisk will generate new stem cell lines to be used in future cell therapies to treat Type 1 Diabetes, Parkinson’s and chronical heart failure. Are you ready to make a difference?

The Position

The Associate Director is an expert in medical writing and performs work independently with minimal-to-no supervision. The Associate Director will work closely with cross-functional project teams, including Medical & Science, Clinical Operations, Biometrics, and Regulatory Affairs personnel, to manage preparation of the written deliverables that support the clinical development and regulatory requirements of a clinical program. The Associate Director will provide high level strategic input into development plans, study designs, and regulatory submissions.

Relationships

The Associate Director, Medical Writing (ADMW) reports to a Director of Medical Writing. The Associate Director is expected to develop and maintain a strong network of internal relationships with global and local cross-functional study teams. The Associate Director should be seen as a key resource for medical writing expertise and provides active leadership on local and global project teams, as needed. The Associate Direct will provide mentoring and direction to less-experienced medical writers, as needed. The Associate Director may supervise other members of the Medical Writing team.

Essential Functions

• Provides strategic input into documents and plans to support clinical operations and regulatory submissions across a range of development programs and therapeutic areas:

• Uses professional experience to provide advanced input into study designs, analysis plans, and regulatory submissions/ applications

• Analyzes proposed study plans and related documents for their ability to deliver the information required by the target audience

• Collaborates with others to develop key messages for complex clinical/regulatory documents

• Authors, reviews, and/or edits documents to support clinical trials and regulatory submissions, which may include:

• Clinical summary and overview documents in eCTD format for global regulatory submissions, including investigational medicinal product dossiers (IMPD), investigational new drug applications (IND), clinical trial applications (CTA), marketing authorization applications (MAA), and new drug applications (NDA)

• Deliverables for meetings with Regulatory Agencies (meeting requests, briefing books, slides, minutes)

• Clinical study protocols and protocol amendments

• Clinical study reports (CSR)

• Investigator brochures (IB)

• Responses to requests from regulatory agencies and ethics committees

• Informed consent and assent forms

• Lay summaries of clinical trial results

• Clinical evaluation plans (CEP) and clinical evaluation reports (CER)

• Pediatric investigational plans (PIP)

• Orphan Drug applications

• Breakthrough Therapy Designation requests

• Leads the sharing of better practices to optimize the way we work and increase awareness of medical writing within the project area:

• Shares project specific and general medical writing practices with other Medical Writers and contributes to process improvements within the project area and globally

• Promotes awareness of medical writing practices and ideas and sets medical writing standards within the project area

• Routinely presents medical writing information to management

• Actively participates in relevant meetings, training sessions, and seminars in the department and relevant project(s)

• General Tasks:

• Provides leadership in local and global project teams, facilitates collaboration, and drives decision making

• Leads meetings and drives decisions concerning project/trial-specific medical writing issues. Independently resolves document content issues and questions arising during the writing process

• Assesses the quality of documents; provides findings and clear feedback to document authors

• Interprets and accurately presents clinical and statistical data in a clear, concise format

• Can identify and resolve complex problems related to Medical Writing projects, processes, or tasks, with management support as needed

• Provides mentorship, guidance, or training to less-experienced Medical Writers

• Maintains up-to-date knowledge and understanding of the laws, regulations, industry standards, and company policies/procedures relevant to Medical Writing

• Remains current with respect to the literature on Novo Nordisk therapeutic areas and competitor products

  Physical Requirements

  Approximately 10% overnight travel. May include travel outside the US.

  Qualifications

• Education Level:

• Minimum of BS/BA, preferably in a health-related or scientific discipline

• Experience Level:

• Requires 9+ years of relevant experience. Minimum of 8 years clinical/regulatory medical writing experience in a pharmaceutical, biotechnology, or CRO environment

• Equivalent experience with advanced degree or in other settings will be considered

• Specific or technical job skills:

• Demonstrated understanding of clinical research, the drug/device development process, and applicable regulatory guidelines

• Demonstrated understanding of statistical approaches in clinical study design and analysis

• Extensive experience contributing to drug applications with the FDA and EMA. Experience with applications in Japan and China a plus

• Able to collaborate with individuals across different time zones and ensure efficient communication and coordination with team members worldwide

• This role requires adaptability and strong organizational skills to effectively manage projects and meet deadlines across various geographical locations

• Exceptional written and oral communication skills, with mastery of English grammar and punctuation

• Therapeutic area experience with cell therapies or other advanced therapeutics desired

  We commit to an inclusive recruitment process and equality of opportunity for all our job applicants.

  At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.

  Novo Nordisk is an equal opportunity employer. Qualified applicants will receive consideration for employment without regard to race, ethnicity, color, religion, sex, gender identity, sexual orientation, national origin, disability, protected veteran status or any other characteristic protected by local, state or federal laws, rules or regulations.

  If you are interested in applying to Novo Nordisk and need special assistance or an accommodation to apply, please call us at 1-855-411-5290. This contact is for accommodation requests only and cannot be used to inquire about the status of applications.